The net benefit for time-to-event outcome in oncology clinical trials with treatment switching

审查(临床试验) 协变量 估计员 反概率 逆概率加权 加权 统计 临床试验 生存分析 医学 计量经济学 数学 内科学 后验概率 贝叶斯概率 放射科
作者
Musashi Fukuda,Kentaro Sakamaki,Koji Oba
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:20 (6): 670-680
标识
DOI:10.1177/17407745231186081
摘要

The net benefit is an effect measure for any type of endpoint, including the time-to-event outcome, and can provide intuitive and clinically meaningful interpretation. It is defined as the probability of a randomly selected subject from the experimental arm surviving by at least a clinically relevant time longer than a randomly selected subject from the control arm. In oncology clinical trials, an intercurrent event such as treatment switching is common, which potentially causes informative censoring; nevertheless, conventional methods for the net benefit are not able to deal with it. In this study, we proposed a new estimator using the inverse probability of censoring weighting (IPCW) method and illustrated an oncology clinical trial with treatment switching (the SHIVA study) to apply the proposed method under the estimand framework.The net benefit can be estimated using the survival functions of each treatment group. The proposed estimator was based on the survival functions estimated by the inverse probability of the censoring weighting method that can handle covariate-dependent censoring. The simulation study was undertaken to evaluate the operating characteristics of the proposed estimator under several scenarios; we varied the shapes of the survival curves, treatment effect, covariates effect on censoring, proportion of the censoring, threshold of the net benefit, and sample size. We also applied conventional methods (the scoring rules by Péron or Gehan) and the proposed method to the SHIVA study.Our simulation study showed that the proposed estimator provided less biased results under the covariate-dependent censoring than existing estimators. When applying the proposed method to the SHIVA study, we were able to estimate the net benefit by incorporating the information of the covariates with different estimand strategies to address the intercurrent event of the treatment switching. However, the estimates of the proposed method and those of the aforementioned conventional methods were similar under the hypothetical strategy.We proposed a new estimator of the net benefit that can include covariates to account for the possibly informative censoring. We also provided an illustrative analysis of the proposed method for the oncology clinical trial with treatment switching using the estimand framework. Our proposed new estimator is suitable for handling the intercurrent events that can potentially cause covariate-dependent censoring.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
wjx发布了新的文献求助10
刚刚
amberzyc完成签到,获得积分10
刚刚
疚祠发布了新的文献求助10
刚刚
刚刚
orixero应助欣慰的乌冬面采纳,获得10
1秒前
meng发布了新的文献求助10
1秒前
端庄的月光完成签到 ,获得积分10
2秒前
2秒前
领导范儿应助hh采纳,获得10
2秒前
星辰大海应助Fin2046采纳,获得10
3秒前
量子星尘发布了新的文献求助10
3秒前
3秒前
zwenng发布了新的文献求助10
3秒前
4秒前
5秒前
小饼干完成签到,获得积分10
5秒前
白白SAMA123完成签到,获得积分10
6秒前
蒲公英发布了新的文献求助10
6秒前
梦想里发布了新的文献求助10
8秒前
执剑燃此生完成签到,获得积分10
9秒前
9秒前
shinn发布了新的文献求助10
10秒前
10秒前
11秒前
11秒前
楚舜华发布了新的文献求助10
11秒前
11秒前
12秒前
练习时长两年半应助variant采纳,获得10
13秒前
打打应助刘潮汕采纳,获得10
14秒前
14秒前
wjx发布了新的文献求助30
14秒前
二零发布了新的文献求助10
14秒前
共享精神应助Jian采纳,获得10
14秒前
15秒前
周杰伦发布了新的文献求助10
15秒前
NINI完成签到,获得积分10
16秒前
wangerer发布了新的文献求助30
16秒前
小饼干发布了新的文献求助10
16秒前
17秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975165
求助须知:如何正确求助?哪些是违规求助? 3519595
关于积分的说明 11198781
捐赠科研通 3255912
什么是DOI,文献DOI怎么找? 1798001
邀请新用户注册赠送积分活动 877343
科研通“疑难数据库(出版商)”最低求助积分说明 806298